ANDROGENETIC ALOPECIA

This early-stage trial tested the safety of a new topical gel called AH-001 in 64 healthy volunteers and men with male pattern baldness. Participants received either a single dose or daily doses for a week of the gel or a placebo. The study focused on side effects and how the dru…

This study tested a new way to take minoxidil for male pattern baldness: a tablet placed under the tongue. 142 men with moderate to severe hair loss took either the minoxidil tablet or a placebo twice daily for 24 weeks. The goal was to see if this method increases hair count and…

This study tested a gel called PP405 for male and female pattern baldness. 78 adults used the gel or a placebo for 28 days, then everyone could use the real gel for 3 more months. The main goals were to check safety and how the body processes the drug.

This study tested a special mineral-ionic formula called THERAVEX REGENERA in 20 adults with hair loss. The treatment was used during hair transplant procedures and as a scalp therapy to help hair follicles grow back. Researchers checked safety and measured changes in hair densit…

This study tested whether adding the antibiotic rifampicin to the standard antiseptic povidone-iodine could prevent infections and improve healing after hair transplants. 65 adults were randomly assigned to receive either the combo or povidone-iodine alone before surgery. Researc…

This study tested a special shampoo for people with hair loss from telogen effluvium or early male/female pattern baldness. 40 adults used the shampoo for 3 months. The goal was to see if it improved hair length and thickness. The study is now complete.